National Institute of Allergy and Infectious Diseases
Bethesda, Maryland, United States
Purpose
to evaluate drugs and regimens to identify those with the greatest potential to significantly reduce the duration of chemotherapy for all tuberculosis patients
Division
Global Health
Date
February 2018
Region Served
GLOBAL
Committed amount
$3,829,122
Grant topic
Tuberculosis
Duration (months)
72
Grantee location
Bethesda, Maryland, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.